C. diff (Clostridioides difficile) Symptoms and When to Get Help

What is C. diff and why does it happen?

Clostridioides difficile (formerly Clostridium difficile) is a spore-forming bacterium that can colonize the colon and produce toxins (toxins A and B) that damage its lining. Under normal circumstances, the healthy gut microbiome keeps C. diff in check. Antibiotics — especially broad-spectrum ones — disrupt that balance by killing off the protective bacteria, allowing C. diff to grow unchecked 1Ref 1Kelly CR, Fischer M, Allegretti JR, LaPlante K, Stewart DB, Limketkai BN, Stollman NH (2021).ACG Clinical Guidelines: Prevention, Diagnosis, and Treatment of Clostridioides difficile Infections.Risk factors, symptom severity classification (mild/moderate/severe/fulminant), diagnostic testing approach, treatment with vancomycin/fidaxomicin, FMT for recurrent CDI, and recurrence rates.

Antibiotic use is the single most common risk factor. Other factors that increase susceptibility include 1Ref 1Kelly CR, Fischer M, Allegretti JR, LaPlante K, Stewart DB, Limketkai BN, Stollman NH (2021).ACG Clinical Guidelines: Prevention, Diagnosis, and Treatment of Clostridioides difficile Infections.Risk factors, symptom severity classification (mild/moderate/severe/fulminant), diagnostic testing approach, treatment with vancomycin/fidaxomicin, FMT for recurrent CDI, and recurrence rates2Ref 2Centers for Disease Control and Prevention (2024).C. diff: Facts for Clinicians.Epidemiology (C. diff accounts for 15-25% of antibiotic-associated diarrhea), transmission via contaminated surfaces, spore resistance to alcohol sanitizers, and risk factors including age and healthcare exposure: - Being 65 or older - Recent hospitalization or long-term care facility stay - A weakened immune system - Prior C. diff infection - Exposure to specific antibiotic classes (fluoroquinolones, cephalosporins, clindamycin, carbapenems)

C. diff spreads through contact with contaminated surfaces and is transmitted via the fecal-oral route. Its spores are resistant to many standard cleaning products, including alcohol-based hand sanitizers 2Ref 2Centers for Disease Control and Prevention (2024).C. diff: Facts for Clinicians.Epidemiology (C. diff accounts for 15-25% of antibiotic-associated diarrhea), transmission via contaminated surfaces, spore resistance to alcohol sanitizers, and risk factors including age and healthcare exposure.

What are the symptoms of C. diff?

Symptoms typically begin during antibiotic treatment or within two to eight weeks after stopping antibiotics — though onset outside this window is possible.

Mild to moderate C. diff [1]: - Watery diarrhea, typically three or more times per day - Crampy abdominal pain or tenderness - Nausea - Mild fever

Severe C. diff: - Diarrhea occurring ten or more times per day - Significant abdominal pain and distension - Fever (often higher) - Signs of dehydration — dry mouth, decreased urination, dizziness

Fulminant C. diff (uncommon but serious) [1]: - Rapid deterioration with low blood pressure, rapid heart rate, and severely distended abdomen - This is a medical emergency requiring immediate hospital care

Not all diarrhea after antibiotics is C. diff — antibiotic-associated diarrhea from other causes is actually more common — but C. diff should be considered when diarrhea is frequent, persistent, or accompanied by significant pain.

How is C. diff diagnosed?

Diagnosis requires a stool test. Testing typically looks for 1Ref 1Kelly CR, Fischer M, Allegretti JR, LaPlante K, Stewart DB, Limketkai BN, Stollman NH (2021).ACG Clinical Guidelines: Prevention, Diagnosis, and Treatment of Clostridioides difficile Infections.Risk factors, symptom severity classification (mild/moderate/severe/fulminant), diagnostic testing approach, treatment with vancomycin/fidaxomicin, FMT for recurrent CDI, and recurrence rates: - C. diff toxin (toxins A and B, the ones that damage the colon lining) - Glutamate dehydrogenase (GDH) antigen — a screening marker - Nucleic acid amplification testing (NAAT/PCR) — a highly sensitive molecular test for C. diff toxin genes

Clinicians will usually order a combination test to balance sensitivity and specificity. A single negative test in someone with strong clinical suspicion may prompt repeat testing or additional evaluation.

Colonoscopy is not routinely needed for diagnosis, but may be done if the clinical picture is unclear or to assess the severity of colitis.

How is C. diff treated?

C. diff is treated with targeted antibiotics. Vancomycin and fidaxomicin are the preferred agents for initial treatment in most cases; fidaxomicin is associated with a lower recurrence rate in some studies. Metronidazole is an alternative in certain settings. The choice depends on infection severity and whether it is a first episode or a recurrence 1Ref 1Kelly CR, Fischer M, Allegretti JR, LaPlante K, Stewart DB, Limketkai BN, Stollman NH (2021).ACG Clinical Guidelines: Prevention, Diagnosis, and Treatment of Clostridioides difficile Infections.Risk factors, symptom severity classification (mild/moderate/severe/fulminant), diagnostic testing approach, treatment with vancomycin/fidaxomicin, FMT for recurrent CDI, and recurrence rates.

If C. diff developed while you were taking another antibiotic, that antibiotic should be stopped if clinically possible — removing the cause of the disrupted microbiome supports recovery.

For people with recurrent C. diff (multiple episodes), fecal microbiota transplant (FMT) — transplanting stool from a healthy donor to restore a healthy gut microbiome — has become an established and highly effective treatment option. Two FDA-approved microbiome-based treatments (Rebyota, approved 2022; Vowst, approved 2023) are now available for this purpose 1Ref 1Kelly CR, Fischer M, Allegretti JR, LaPlante K, Stewart DB, Limketkai BN, Stollman NH (2021).ACG Clinical Guidelines: Prevention, Diagnosis, and Treatment of Clostridioides difficile Infections.Risk factors, symptom severity classification (mild/moderate/severe/fulminant), diagnostic testing approach, treatment with vancomycin/fidaxomicin, FMT for recurrent CDI, and recurrence rates.

C. diff cannot be self-treated. It requires a clinician's assessment, stool testing, and prescription treatment. Gale's primary care team can evaluate your symptoms and arrange testing, or refer you to a gastroenterologist for recurrent or severe cases.

Can C. diff come back after treatment?

Recurrence is one of the most challenging aspects of C. diff management. Approximately one in five people who complete treatment will experience at least one recurrence. Each recurrence increases the risk of additional episodes 1Ref 1Kelly CR, Fischer M, Allegretti JR, LaPlante K, Stewart DB, Limketkai BN, Stollman NH (2021).ACG Clinical Guidelines: Prevention, Diagnosis, and Treatment of Clostridioides difficile Infections.Risk factors, symptom severity classification (mild/moderate/severe/fulminant), diagnostic testing approach, treatment with vancomycin/fidaxomicin, FMT for recurrent CDI, and recurrence rates.

Strategies to reduce recurrence risk include: - Completing the full course of prescribed treatment - Avoiding unnecessary antibiotics in the future - Good hand hygiene — soap and water is more effective than alcohol hand sanitizer against C. diff spores 2Ref 2Centers for Disease Control and Prevention (2024).C. diff: Facts for Clinicians.Epidemiology (C. diff accounts for 15-25% of antibiotic-associated diarrhea), transmission via contaminated surfaces, spore resistance to alcohol sanitizers, and risk factors including age and healthcare exposure - Probiotic use during and after antibiotic treatment has been studied, with modest evidence for certain strains reducing recurrence risk in high-risk patients